Fatal hemorrhagic cystitis induced by pelvic irradiation and cyclophosphamide therapy. Case reports and review.
The potent cytotoxic drug cyclophosphamide has been used extensively for neoplastic and non-neoplastic diseases. Patients taking this drug may have received or may be receiving pelvic irradiation concurrently. This report describes two patients who developed fatal hemorrhagic cystitis induced by pelvic irradiation and cyclophosphamide therapy. Etiology, incidence, pathologic descriptions, and diagnostic and therapeutic aspects of this entity are described. The incidence and risk of serious, life-threatening bladder hemorrhage from cyclophosphamide therapy is increased by prior or concurrent pelvic irradiation. Alternative cytotoxic, non-urotoxic chemotherapy should be used in these high-risk patients.
Price
W E
WE
University of Minnesota.
Keldahl
L R
LR
D000368:Aged; D000369:Aged, 80 and over; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects*; D003556:Cystitis / Q000209:etiology*; D005260:Female; D006417:Hematuria / Q000209:etiology*; D006801:Humans; D008595:Menorrhagia / Q000532:radiotherapy; D010051:Ovarian Neoplasms / Q000532:radiotherapy; D011832:Radiation Injuries / Q000209:etiology*; D001743:Urinary Bladder / Q000528:radiation effects*; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy
D003520:Cyclophosphamide